1st Quarter - Report

MUSCULAR DYSTROPHY ASSOCIATION, INC. for MUSCULAR DYSTROPHY ASSOCIATION, INC.

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for funding for the FDA Orphan Products Grants Program. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for National Institutes of Health, Food and Drug Administration, Health Resources and Services Administration, and other health agencies that conduct research on neuromuscular disease and provide services to those with these conditions. Advocated for adequate, affordable, accessible health coverage for individuals with neuromuscular conditions. Advocated for maintaining strong incentives for rare disease drug development included within the Orphan Drug Act (PL 97-414) Advocated for reintroduction of the ACT for ALS Act. Advocated for access to healthcare via telemedicine/telehealth throughout and after the COVID-19 public health emergency. Advocated for equitable access to the COVID-19 vaccines for the neuromuscular disease community. Advocated for a variety of items to included within the American Rescue Plan Act (H.R.1319) including Medicaid coverage provisions, marketplace affordability and access provisions, COBRA modifications, and public health provisions pertaining to access to care, treatment, and vaccines.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Centers For Disease Control & Prevention (CDC); Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Federal Aviation Administration (FAA); Food & Drug Administration (FDA)

Bills named: S. 350 (117th), H.R. 1319 (117th), H.R. 482 (117th)

Medicare/Medicaid MMM

Advocated for adequate, affordable, accessible health coverage for individuals with neuromuscular conditions. Cited opposition to the expansion of Section 1115 demonstration waivers that would create substantial barriers to care for patients and families who enroll in Medicaid. Supported enhancements to Medicaid coverage as part of the American Recovery Plan (H.R.1319)

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Transportation, Dept of (DOT); Federal Aviation Administration (FAA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1319 (117th)

Insurance INS

Advocated for adequate, affordable, accessible health coverage for individuals with neuromuscular conditions. Advocated for further health insurance marketplace financial and COBRA enhancements as part of the American Recovery Plan.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Transportation, Dept of (DOT); Federal Aviation Administration (FAA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Aviation/Airlines/Airports AVI

Advocated for the passage of the Air Carrier Access Amendments Act (S.642, H.R.1893) Advocated for further air travel access improvements for individuals with disabilities through regulation by FAA and DoT.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Federal Aviation Administration (FAA)

Bills named: H.R. 1893 (117th), S. 642 (117th)

Labor Issues/Antitrust/Workplace LBR

Advocated for enhanced COBRA benefits for individuals who have lost their job but are seeking insurance.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Health & Human Services, Dept of (HHS); Transportation, Dept of (DOT); Food & Drug Administration (FDA); Federal Aviation Administration (FAA); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Advocated for provisions that enable ongoing access to necessary medications and treatments for neuromuscular disease patients throughout theCOVID-19 pandemic. Advocated for the reintroduction of the ACT for ALS, legislation that should accelerate development of treatments for individuals with ALS and other neuromuscular diseases.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Federal Aviation Administration (FAA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Advocated in favor of robust appropriations funding for the National Institutes of Health, the Food and Drug Administration, the Health Resources and Services Administration, and the Centers for Disease Control and Prevention.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Federal Aviation Administration (FAA)

Taxation/Internal Revenue Code TAX

Advocated for passage of measures that would provide financial assistance to nonprofits providing essential healthcare services to the neuromuscular disease community throughout the COVID-19 pandemic.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Federal Aviation Administration (FAA); Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Advocated for robust funding for the Newborn Screening programs at the CDC, NIH, and HRSA

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Transportation, Dept of (DOT); Federal Aviation Administration (FAA); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.